Group One Trading
CRMD icon

Group One Trading’s CorMedix CRMD Stock Holding History

Group One Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$938K Sell
138,200
-83,700
-38% -$619K ﹤0.01% 2789
2025
Q4 		$2.58M Buy
221,900
+75,300
+51% +$832K ﹤0.01% 2049
2025
Q3 		$1.7M Buy
146,600
+69,300
+90% +$838K ﹤0.01% 2474
2025
Q2 		$952K Buy
77,300
+300
+0.4% +$3.31K ﹤0.01% 2812
2025
Q1 		$474K Buy
77,000
+45,400
+144% +$470K ﹤0.01% 3147
2024
Q4 		$256K Sell
31,600
-36,500
-54% -$365K ﹤0.01% 3741
2024
Q3 		$550K Buy
68,100
+9,800
+17% +$53K ﹤0.01% 2779
2024
Q2 		$252K Buy
58,300
+7,400
+15% +$37.6K ﹤0.01% 3201
2024
Q1 		$216K Buy
50,900
+19,500
+62% +$67.6K ﹤0.01% 3504
2023
Q4 		$118K Buy
31,400
+18,100
+136% +$62.3K ﹤0.01% 4315
2023
Q3 		$49.2K Buy
13,300
+3,200
+32% +$12.7K ﹤0.01% 5109
2023
Q2 		$40K Sell
10,100
-1,300
-11% -$6.43K ﹤0.01% 5450
2023
Q1 		$47.2K Sell
11,400
-23,300
-67% -$95.3K ﹤0.01% 4893
2022
Q4 		$146K Buy
34,700
+17,800
+105% +$63K ﹤0.01% 4116
2022
Q3 		$48K Buy
16,900
+2,600
+18% +$10.8K ﹤0.01% 5435
2022
Q2 		$57K Sell
14,300
-8,100
-36% -$30.1K ﹤0.01% 5447
2022
Q1 		$123K Buy
22,400
+21,400
+2,140% +$98K ﹤0.01% 5294
2021
Q4 		$5K Sell
1,000
-9,600
-91% -$47.7K ﹤0.01% 7624
2021
Q3 		$49K Sell
10,600
-80,900
-88% -$471K ﹤0.01% 6555
2021
Q2 		$628K Buy
91,500
+34,200
+60% +$272K ﹤0.01% 3962
2021
Q1 		$572K Buy
57,300
+20,600
+56% +$217K ﹤0.01% 3863
2020
Q4 		$273K Buy
36,700
+13,100
+56% +$89.1K ﹤0.01% 3816
2020
Q3 		$142K Buy
23,600
+8,600
+57% +$43.2K ﹤0.01% 3919
2020
Q2 		$95K Buy
15,000
+10,200
+213% +$47.2K ﹤0.01% 3948
2020
Q1 		$17K Sell
4,800
-5,600
-54% -$31.6K ﹤0.01% 4310
2019
Q4 		$76K Sell
10,400
-24,400
-70% -$149K ﹤0.01% 3805
2019
Q3 		$222K Sell
34,800
-101,000
-74% -$849K ﹤0.01% 3008
2019
Q2 		$1.22M Sell
135,800
-202,000
-60% -$1.59M 0.01% 1461
2019
Q1 		$3.19M Buy
337,800
+333,320
+7,440% +$3M 0.04% 652
2018
Q4 		$29K Buy
+4,480
New +$30K ﹤0.01% 3828
2017
Q2 		– Sell
-1,400
Closed -$11K – 4785
2017
Q1 		$11K Sell
1,400
-5,740
-80% -$54.8K ﹤0.01% 4085
2016
Q4 		$55K Buy
7,140
+3,900
+120% +$39.5K ﹤0.01% 3211
2016
Q3 		$41K Sell
3,240
-760
-19% -$7.1K ﹤0.01% 3446
2016
Q2 		$40K Buy
4,000
+2,440
+156% +$37.2K ﹤0.01% 3435
2016
Q1 		$21K Sell
1,560
-3,000
-66% -$29.1K ﹤0.01% 3712
2015
Q4 		$46K Sell
4,560
-180
-4% -$2.07K ﹤0.01% 3454
2015
Q3 		$47K Sell
4,740
-4,280
-47% -$66K ﹤0.01% 3555
2015
Q2 		$175K Sell
9,020
-1,680
-16% -$57.6K ﹤0.01% 2631
2015
Q1 		$526K Buy
+10,700
New +$254K 0.01% 1553

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CRMD Position: Q1 2026 in Review

Group One Trading sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 1,368 shares — an estimated $10.1K sold.

Group One Trading first reported a position in CRMD in Q1 2015 and held it in 35 quarters. The position peaked at $2.6M in Q3 2024. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Group One Trading reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 1,368 CorMedix shares in Q1 2026, an estimated $10.1K.
  • Group One Trading first reported a position in CorMedix in Q1 2015 and held it in 35 quarters.
  • Group One Trading's CorMedix position peaked at $2.6M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.